A recent report shared by the Centers for Disease Control adds evidence that shows the HPV vaccine is actually preventing cancer in young women. According to the Morbidity and Mortality Weekly Report, since the vaccine was first introduced as a preventive measure for cervical cancer and many other diseases in 2006, the results have been promising. As you may know, many young adolescent girls who were vaccinated have now become eligible for cervical cancer screening, which is about 21-26 years old, which revealed how the vaccine has been faring and whether it had any results. The reason why this report was added was to reveal how during 2008 – 2022 cervical precancer incidence decreased by about 79% and for the higher grade precancer incidence came down by about 80% among all the women who were screened between the ages of 20-24 years. They explained how the decline in cervical precancers is consistent with the HPV vaccine and supported the recommendations by the Advisory Committee on Immunization Practices to vaccinate children against HPV at the age of 11-12 with catch-up through age 26. Why Is It Important To Understand HPV and the Vaccine's Impact?HPV is a common virus, and many people get it. Most of the time, it goes away on its own. But sometimes, it can cause serious problems, like cancer. The HPV vaccine helps the body fight off the virus, so it can't cause those problems. Because the vaccine is given to young people, it can protect them before they are exposed to the virus. By preventing the infection, the vaccine stops the virus from causing changes that could lead to cancer. This protection is long-term and gives great protection for people who have received the vaccine. According to the National Cancer Institute, the goal of the screening is to find precancerous cervical cell changes so the treatment can prevent the cells from growing any further. They explain how by the time symptoms of cervical cancer manifest as a physical issue, it is already too late to be treated, so it is best to treat it as early as possible. The age-eligibility of the cervical cancer screening is 21-29 and the USPSTF recommends they get their first pap test at age 21 followed by one every three years. For the age group, 30-65 USPSTF recommends either an HPV test every five years, HPV/Pap cotest every five years, or a Pap test every three years. What We Need To Know About Cervical Cancer As we know cervical cancer is a cancer that can be found anywhere in the cervix and anyone with a cervix can have it. According to the NHS UK, nearly all cervical cancers are caused by an infection from different types of Human Papillomavirus or HPV, it also develops very slowly, hence showing fewer symptoms, until it is too late. Those symptoms include, Unusual vaginal bleeding, which includes during or after intercourse, between your periods or after menopause, or having heavier periods. Changes in vaginal discharge Painful sexual intercourse Pain in your lower back, in your lower tummy as well as your pelvis (between your hip bones)The NHS also explains how these could be signs of fibroids or endometriosis, but it is best to go get checked if the symptoms change or get worse. How Does The New Report Affect Public Health? The new report from the CDC provides solid proof that the HPV vaccine works. When scientists conduct studies and publish reports, it adds weight to previous findings. In this case, it backs up the idea that the vaccine is doing its job. "Confirms" means that the report agrees with and strengthens what we already know. This is important because it gives doctors and parents more confidence in recommending the vaccine. The data within the report allows for a higher level of trust, and more informed decisions about health. The data provided by the CDC is a very important tool for public health officials.